| Year | Federal $ expended | Auditor | Opinion | Flags |
|---|---|---|---|---|
| 2025 | $45.6M | Suplee Clooney and Company | Unmodified (clean) | Low-risk auditee |
| 2024 | $57.0M | Suplee, Clooney and Company LLC | Unmodified (clean) | Low-risk auditee |
| 2023 | $45.6M | Suplee, Clooney and Company LLC | Unmodified (clean) | Low-risk auditee |
| 2022 | $1.1M | Suplee Clooney and Company | Unmodified (clean) | Low-risk auditee |
| Program | Agency | Expended | Major program | Findings |
|---|---|---|---|---|
| Epidemiology and Laboratory Capacity for Infectious Diseases (elc) via Dept. of Health and Human Services Centers for Disease Control and Prevention | HHS | $35.7M | Yes | 0 |
| Epidemiology and Laboratory Capacity for Infectious Diseases (elc) via Dept. of Health and Human Services Centers for Disease Control and Prevention | HHS | $9.3M | Yes | 0 |
| Coronavirus Relief Fund via Dept. of Health and Human Services Centers for Disease Control and Prevention | Treasury | $577K | No | 0 |
| Hospital Preparedness Program (hpp) and Public Health Emergency Preparedness (phep) Aligned Cooperative Agreements via Dept. of Health and Human Services Centers for Disease Control and Prevention | HHS | $42K | No | 0 |
| CDC Partnership: Strengthening Public Health Laboratories via Dept. of Health and Human Services Centers for Disease Control and Prevention | HHS | $0 | No | 0 |